Antitrust Antitrust

Surescripts's efforts to end loyalty programs do not render US FTC case moot, judge says

By Chris May and Khushita Vasant
  • 16 Mar 2023 21:29
  • 16 Mar 2023 21:29
The US Federal Trade Commission's lawsuit against Surescripts alleging monopolization of the electronic prescriptions market is not moot, a US judge said today, and he questioned counsel for both sides on their analysis of the e-prescription network's market power and impact on competition.
Surescripts said in a recent letter to

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Khushita Vasant

Chief Antitrust Correspondent, US

Khushita covers US antitrust enforcement and litigation for MLex. A former Brussels hand, she wrote about about antitrust & mergers for the Policy and Regulatory Report (PaRR), she has covered the EU's actions against Google, Apple, Facebook and Amazon to name a few. Khushita specialises in tech and patent policy coverage which featured in the Concurrences Antitrust Writing Awards. Previously as a financial journalist for The Wall Street Journal and Dow Jones Newswires, she wrote about monetary policy and the bond and currency markets. Khushita studied journalism at Mumbai University, and received an Erasmus Mundus scholarship for a masters from universities in Germany and Austria.

Discover MLex

Stay on top of global regulatory developments

Latest News